A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable ...

Patients with HER2-positive advanced breast cancers had the greatest benefits, with survival improvements ranging from ...

Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to ...

A cellular resistance mechanism at the origin of relapses of triple-negative breast cancer has recently been discovered by ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Our experts agree that there are many simple ways to minimize the chances of breast cancer returning. Adopting a healthy ...

Pink Alliance's 22nd annual 'Surviving and Thriving' Luncheon is an event that raises vital funds for local breast cancer ...

Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis ...

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.

The team, led by oncologist Dr. Angela DeMichele, has advanced a method to identify and attack these dormant cells. Called ...

The breakthrough gives new options for patients whose cancers no longer respond to existing therapies. The post New antibody ...

A newly developed antibody that restricts the growth of treatment-resistant breast cancers offers new hope for patients. It ...